Laman UtamaAIM • NYSEAMERICAN
add
AIM ImmunoTech Inc
$2.59
Selepas Waktu Dagangan:(0.39%)+0.010
$2.60
Tutup: 12 Sep, 5:07:01 PTG GMT-4 · USD · NYSEAMERICAN · Penafian
Tutup sebelumnya
$2.59
Julat hari
$2.53 - $2.67
Julat tahun
$2.33 - $20.35
Permodalan pasaran
7.02J USD
Bilangan Purata
77.89K
Nisbah P/E
-
Hasil dividen
-
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD) | Jun 2025info | Perubahan T/T |
---|---|---|
Hasil | 25.00K | -50.00% |
Perbelanjaan pengendalian | 2.66J | -28.77% |
Pendapatan bersih | -2.79J | -52.18% |
Margin untung bersih | -11.18K | -204.36% |
Pendapatan bagi setiap syer | -3.68 | -22.67% |
EBITDA | -2.59J | 28.68% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(USD) | Jun 2025info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 835.00K | -91.70% |
Jumlah aset | 4.13J | -73.73% |
Jumlah liabiliti | 10.68J | 11.05% |
Jumlah ekuiti | -6.55J | — |
Syer tertunggak | 2.71J | — |
Harga kepada buku | -0.30 | — |
Pulangan pada aset | -127.49% | — |
Pulangan pada modal | 260.64% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(USD) | Jun 2025info | Perubahan T/T |
---|---|---|
Pendapatan bersih | -2.79J | -52.18% |
Tunai daripada operasi | -1.53J | 49.10% |
Tunai daripada pelaburan | 754.00K | -8.72% |
Tunai daripada pembiayaan | 355.00K | -85.46% |
Perubahan bersih dalam tunai | -422.00K | -262.93% |
Aliran tunai bebas | -1.37J | 65.91% |
Perihal
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Diasaskan
1966
Ibu pejabat
Tapak web
Pekerja
22